AC Immune
ACIU
57 hedge funds and large institutions have $144M invested in AC Immune in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 10 closing their positions.
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
57% more call options, than puts
Call options by funds: $2.14M | Put options by funds: $1.36M
12% more funds holding
Funds holding: 51 → 57 (+6)
4% more capital invested
Capital invested by funds: $139M → $144M (+$5.75M)
0% more ownership
Funds ownership: 25.04% → 25.04% (+0%)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$10.9M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$7.19M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.95M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.6M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
-$19.9M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$6.91M |
| 3 |
BlackRock
New York
|
-$1.91M |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$1.47M |
| 5 |
Millennium Management
New York
|
-$1.21M |
ACIU Hedge Fund Activity: Q2 2021 in Review
57 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2021, worth a combined $144M — up 4.2% from $139M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ACIU positions and 10 closed out — a net gain of 6 holders — while 16 added to existing stakes and 18 trimmed.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $10.9M. The largest seller was Temasek Holdings, exiting entirely with an estimated $19.9M sold.
- 57 institutional investors held AC Immune (ACIU) as of Q2 2021, up from 51 in Q1 2021.
- Funds reported $144M of AC Immune stock for Q2 2021, up 4.2% quarter-over-quarter.
- 16 funds opened new AC Immune positions in Q2 2021 and 10 closed out, a net change of +6 holders.
- The largest AC Immune buyer in Q2 2021 was Avidity Partners Management, an estimated $10.9M added.
- The largest AC Immune seller in Q2 2021 was Temasek Holdings, an estimated $19.9M sold.
Based on aggregated 13F filings for Q2 2021.